ES2147749T3 - Procedimiento para la preparacion de derivados de ciano-metoxiiminometilo. - Google Patents

Procedimiento para la preparacion de derivados de ciano-metoxiiminometilo.

Info

Publication number
ES2147749T3
ES2147749T3 ES93903271T ES93903271T ES2147749T3 ES 2147749 T3 ES2147749 T3 ES 2147749T3 ES 93903271 T ES93903271 T ES 93903271T ES 93903271 T ES93903271 T ES 93903271T ES 2147749 T3 ES2147749 T3 ES 2147749T3
Authority
ES
Spain
Prior art keywords
metoxiiminometilo
ciano
derivatives
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93903271T
Other languages
English (en)
Spanish (es)
Inventor
Mark Jason Hughes
John Kitteringham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Application granted granted Critical
Publication of ES2147749T3 publication Critical patent/ES2147749T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
ES93903271T 1992-02-20 1993-02-11 Procedimiento para la preparacion de derivados de ciano-metoxiiminometilo. Expired - Lifetime ES2147749T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929203688A GB9203688D0 (en) 1992-02-20 1992-02-20 Novel process

Publications (1)

Publication Number Publication Date
ES2147749T3 true ES2147749T3 (es) 2000-10-01

Family

ID=10710781

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93903271T Expired - Lifetime ES2147749T3 (es) 1992-02-20 1993-02-11 Procedimiento para la preparacion de derivados de ciano-metoxiiminometilo.

Country Status (18)

Country Link
US (2) US5545740A (en, 2012)
EP (2) EP0984008A3 (en, 2012)
JP (1) JP3288704B2 (en, 2012)
KR (1) KR100261530B1 (en, 2012)
AT (1) ATE194341T1 (en, 2012)
AU (1) AU669355B2 (en, 2012)
CA (1) CA2131019C (en, 2012)
DE (1) DE69328962T2 (en, 2012)
DK (1) DK0626961T3 (en, 2012)
ES (1) ES2147749T3 (en, 2012)
GB (1) GB9203688D0 (en, 2012)
GR (1) GR3034295T3 (en, 2012)
MX (1) MX9300875A (en, 2012)
NZ (1) NZ246940A (en, 2012)
PT (1) PT626961E (en, 2012)
TW (1) TW224466B (en, 2012)
WO (1) WO1993017018A1 (en, 2012)
ZA (1) ZA931132B (en, 2012)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9300875A (es) 1992-02-20 1993-08-31 Smithkline Beecham Plc Procedimiento para la preparacion de compuestos azabiciclicos.
GB9409705D0 (en) * 1994-05-14 1994-07-06 Smithkline Beecham Plc Novel compounds
GB9421472D0 (en) * 1994-10-25 1994-12-07 Smithkline Beecham Plc Novel methods
GB9615628D0 (en) * 1996-07-25 1996-09-04 Smithkline Beecham Plc Formulation
EP1009403A4 (en) * 1997-04-11 2002-08-28 Lilly Co Eli METHOD FOR TREATING SCHIZOPHRENIA
JP2002503224A (ja) * 1997-04-11 2002-01-29 エリ リリー アンド カンパニー 疼痛を処置するための組成物
US7678363B2 (en) * 2005-08-26 2010-03-16 Braincells Inc Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
US7985756B2 (en) 2005-10-21 2011-07-26 Braincells Inc. Modulation of neurogenesis by PDE inhibition
CA2625210A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
WO2007134077A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
WO2007134136A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
KR20090064418A (ko) 2006-09-08 2009-06-18 브레인셀즈 인코퍼레이션 4-아실아미노피리딘 유도체 포함 조합물
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1600969A (en) 1977-01-07 1981-10-21 Acf Chemiefarma Nv Heterocyclic compounds
US4937239A (en) * 1989-02-13 1990-06-26 Warner-Lambert Company Azabicycloalkane oxime & azabicycloalkene oxime muscarinic agents
DK0392803T3 (da) * 1989-04-13 2004-10-18 Beecham Group Plc Hidtil ukendte forbindelser
US5418240A (en) 1990-08-21 1995-05-23 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
DK198590D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
MX9300875A (es) 1992-02-20 1993-08-31 Smithkline Beecham Plc Procedimiento para la preparacion de compuestos azabiciclicos.

Also Published As

Publication number Publication date
WO1993017018A1 (en) 1993-09-02
EP0626961A1 (en) 1994-12-07
PT626961E (pt) 2000-10-31
AU3460793A (en) 1993-09-13
CA2131019C (en) 2002-12-24
EP0984008A3 (en) 2000-05-03
EP0626961B1 (en) 2000-07-05
ATE194341T1 (de) 2000-07-15
DE69328962T2 (de) 2000-12-28
HK1012366A1 (en) 1999-07-30
GB9203688D0 (en) 1992-04-08
TW224466B (en, 2012) 1994-06-01
EP0984008A2 (en) 2000-03-08
JPH07504180A (ja) 1995-05-11
JP3288704B2 (ja) 2002-06-04
NZ246940A (en) 1996-06-25
DK0626961T3 (da) 2000-11-06
MX9300875A (es) 1993-08-31
DE69328962D1 (de) 2000-08-10
US6596869B2 (en) 2003-07-22
AU669355B2 (en) 1996-06-06
KR950700292A (ko) 1995-01-16
CA2131019A1 (en) 1993-08-21
KR100261530B1 (ko) 2000-08-01
US20020143185A1 (en) 2002-10-03
GR3034295T3 (en) 2000-12-29
ZA931132B (en) 1993-10-14
US5545740A (en) 1996-08-13

Similar Documents

Publication Publication Date Title
ES2147749T3 (es) Procedimiento para la preparacion de derivados de ciano-metoxiiminometilo.
HUT59109A (en) Process for producing hydroxymethyl-(methylenecyclopentyl)-purines and -pyrimidines, their pharmaceutically acceptable salts and pharmaceutical compositions comprising same
MX9200817A (es) Derivados de piranil cianoguanidina y proceso para su preparacion.
HUT57043A (en) Process for producing pharmaceutical solutions comprising macrolide
ES2103753T3 (es) Procedimiento para la preparacion de derivados de clorotiazol.
DE3775882D1 (de) Substituierte 6-fluor-4-oxo-1,4-dihydrochinolin-3-carbonsaeuren ; deren derivate; diese verbindung enthaltende pharmazeutische zubereitungen und verfahren zur herstellung dieser verbindungen.
ES8606282A1 (es) Un procedimiento de preparar derivados de acidos quinolin- ynaftiridin-carboxilicos
PT83104B (en) Novel guanidinomethylbenzoic acid derivatives
PT87277A (pt) Process for the preparation of new bicyclic compounds and pharmaceutical compositions comprising same
BR9502079A (pt) Composto,formulação farmaceutica e processo para preparar um composto
HU910748D0 (en) New substituted amine compounds and process for producing them
ES2123520T3 (es) 1-piperazinil-2-butenos y 2-butinos, productos intermedios de los mismos, un procedimiento para su preparacion y su uso como medicamentos.
ES2196174T3 (es) `derivados de sesquiterpeno de actividad antiviral.
ES2033256T3 (es) Procedimiento para preparar derivados fluorados de la vitamina d3.
HU912216D0 (en) Process for the production of purinyl-and pirimidinyl - tetrahydrofurane derivatives and medical preparations containing them
FI933928A0 (fi) Heteroarenylpiperaziner, foerfarande foer framstaellning av dessa och anvaendning som laekemedel
DK162188D0 (da) Fremgangsmaade til fremstilling af pentandionderivater
EP0450232A3 (en) P-guanidino benzoic acid derivatives for treatment of cerebrovascular contraction
ES2164258T3 (es) Procedimiento de preparacion de derivados de carbamoilmetilurea.
ES2039270T3 (es) Derivados de gamma-l-glutamil-4-nitroanilida y procedimiento para determinar actividad de gamma-gtp utilizandolos.
DE3781044D1 (de) Prophylaktische und heilende zusammensetzung enthaltende eine 8-chlorbenzothiazepin-verbindung und dessen verwendung.
ATE109454T1 (de) Catecholaminester.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 626961

Country of ref document: ES